Article citationsMore>>

Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J, Barradas, M., Benguría, A., Zaballos, A., Flores, J.M., Barbacid, M., Beach, D. and Serrano, M. (2005) Tumour Biology: Senescence in Premalignant Tumours. Nature, 436, 642.
http://dx.doi.org/10.1038/436642a

has been cited by the following article:

• TITLE: Radiation Induced Bystander Effect: From in Vitro Studies to Clinical Application

  AUTHORS: Maria Widel

  KEYWORDS: Radiation-Induced Bystander Effect, In Vitro Studies, Preclinical Investigation, Radiotherapy, Immunotherapy, Beneficial Abscopal Effect, Carcinogenic Potential, Secondary Cancers

  JOURNAL NAME: International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol.5 No.1, February 3, 2016

  ABSTRACT: In the past 20 years, the classic paradigm in radiobiology recognizing DNA as the main target for the action of radiation has changed. The new paradigm assumes that both targeted and non-targeted effects of radiation determine the final outcome of irradiation. Radiotherapy is one of the main modality treatments of neoplastic diseases with intent to cure, or sometimes to palliate only, thus radiation-induced non-targeted effect, commonly referred to as the radiation-induced bystander effect (RIBE) may have a share in cancer treatment. RIBE is mediated by molecular signaling from radiation targeted cells to their non-irradiated neighbors, and comprises such phenomena as bystander effect, genomic instability, adaptive response and abscopal effect. Whereas first three phenomena may appear both in vitro and in vivo, an abscopal effect is closely related to partial body irradiation and is a systemic effect mediated by immunologic system which synergizes with radiotherapy. From the clinical point of view abscopal effect is particularly interesting due to both its possible valuable contribution to the treatment of metastases, and the potential harmful effects as induction of genetic instability and carcinogenesis. This review summarized the main results of investigations of non-targeted effects coming from in vitro monolayer cultures, 3-dimentional models of tissues, preclinical studies on rodents and clinically observed beneficial abscopal effects with particular emphasis on participation of immunotherapy in the creation of abscopal effects.